HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delayed presentation of urinoma after radiofrequency ablation-assisted laparoscopic partial nephrectomy.

AbstractPURPOSE:
To examine the outcomes and complications of thermal ablation-assisted laparoscopic partial nephrectomy (LPN).
PATIENTS AND METHODS:
Radiofrequency ablation (RFA)-assisted laparoscopic partial nephrectomy was employed in 16 consecutive renal masses with a mean size of 3.0 cm over 12 months. The indications were primarily adjacent bowel, hilar location, or both. After RFA, the renal mass was laparoscopically excised and examined pathologically.
RESULTS:
The mean operative treatment time was 99 minutes. The estimated blood loss was 121 mL, and no patient required a blood transfusion. Urinoma was diagnosed in three patients at an average of 13 days postoperatively and resolved with conservative management or ureteral stent placement.
CONCLUSIONS:
Radiofrequency ablation-assisted LPN provides effective hemostasis and, in the short term, cancer control. In this setting, urinoma presents as ipsilateral flank pain 1 to 2 weeks after surgery. The proposed mechanism for the delayed presentation is thermal injury to the collecting system, although an unrecognized direct collecting-system injury is possible. Conservative management, ureteral stent placement, or both led to resolution of all of the urinomas.
AuthorsMichael G Oefelein
JournalJournal of endourology (J Endourol) Vol. 20 Issue 1 Pg. 27-30 (Jan 2006) ISSN: 0892-7790 [Print] United States
PMID16426128 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Aged
  • Carcinoma, Renal Cell (pathology, surgery)
  • Catheter Ablation (adverse effects, methods)
  • Follow-Up Studies
  • Humans
  • Kidney Neoplasms (pathology, surgery)
  • Laparoscopy
  • Middle Aged
  • Nephrectomy (adverse effects, methods)
  • Postoperative Complications
  • Retrospective Studies
  • Time Factors
  • Tomography, X-Ray Computed
  • Urine
  • Urologic Diseases (diagnostic imaging, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: